Astellas is a pharmaceutical company committed to turning innovative science into value for patients.
Astellas Established Markets-Commercial (EST-C) operates in 37 countries, speaking 23 main languages, and is a regional business of Tokyo-based Astellas Pharma Inc.
The EST-C region headquarters are based in the UK, and support the affiliate teams across Europe, Australia and Canada, working in collaboration with the Manufacturing and Medical & Development sites in Ireland and the Netherlands.
We are determined to answer the unmet medical needs of people around the world. Building on our heritage in a diverse range of therapeutic areas, we continue to invest in research and development to support new medicines and technologies.
The passion of our 3,500+ people throughout the region help us to continue to make a difference to the lives of patients and our values of patient focus, ownership, results, openness and integrity guide us in everything that we do.
NON_2019_0044_APE. November 2019